prof. dr. M. (Michiel) Rienstra

Arrhythmias, in particular Atrial fibrillation; Heart failure; Implantable cardiac devices

initiator HartNet Noord-Nederland
chair Dutch Society of Cardiology Science and Innovation committee
Member board DCVA pillar Research Policy
member Netherlands Heart Institute scientific council
member AFFECT-EU advisory board (EH H2020)
member Norwegian Exercise and Atrial Fibrillation Initiative (NEXAF) advisory board
workpackage leader EHRA-PATHS project (EU H2020)
co-principal investigator DECISION trial (DHF, Disphar/Teva/Tiopharma)
investigator CVON-AI consortium (DHF, CVON)
work-package leader RED-CVD consortium (DHF, CVON)
werkpakket leider RACE V consortium (DHF, CVON)
co-principal investigator VIP-HF study (Abbott to the institution)
workpackage leader MyDigiTwin project (COMMIT2DATA, NWO, DHF)
co-principal investigator RACE 3 trial (DHF)
co-principal investigator RACE 8-HF trial (ZonMW)
co-principal investigator MARC 2 study (Medtronic to MUMC+))
investigator MONITOR-HF study (Abbott)
investigator Cryo-balloon AF study (Medtronic)
investigator Hybrid AF ablation study (AtriCure)
national principal investigator RESTORE-1 trial (InCarda Therapeutics to the institution)
Member Heart Rhythm O2 editorial board
member steering committee RACE 9 trial (ZonMW)
principal investigator New biomarkers in AF project (Roche to the institution)
Embassador Netherlands Heart Institute
principal investigator EmbRACE network project (DCVA/DHF)
co-principal investigator Groningen-Hamburg PROGRESS-AF study
national principal investigator OCEANIC-AF trial (Bayer to the institution)